VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 150 · 118th Congress

Affordable Prescriptions for Patients Act of 2023

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Passed the Senate without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 118th Congress ended.

8 cosponsors · 4 D, 4 R

5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

  1. Senate Introduced Jan 30, 2023
  2. Senate Passed Jul 11, 2024

This bill limits in certain instances the number of patents that a reference biological product manufacturer can assert in a patent infringement lawsuit against a company seeking to sell a biosimilar version.

What it does: CRS summary · Passed Senate · Jul 11, 2024

Affordable Prescriptions for Patients Act of 2023

This bill limits in certain instances the number of patents that a reference biological product manufacturer can assert in a patent infringement lawsuit against a company seeking to sell a biosimilar version.

Specifically, if the biosimilar manufacturer completes certain actions as part of an abbreviated pathway to get market approval, the bill limits, subject to exceptions and waivers, the number of certain types of patents that the reference product manufacturer may assert, such as patents filed more than four years after the reference product received market approval.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Affordable Prescriptions for Patients Act of 2023

Latest action (Jul 15, 2024): Held at the desk.

Policy area: Health · Origin: Senate · Introduced: Jan 30, 2023

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. Senate Introduced Jan 30, 2023
  2. Senate Passed Jul 11, 2024

No recorded floor vote found.